Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.4
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Balance as of beginning of period (in shares) at Dec. 31, 2022   5,477,984      
Balance as of beginning of period at Dec. 31, 2022 $ 138,795 $ 2 $ 361,528 $ (837) $ (221,898)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares) 40,000 129,173      
Issuance of common stock upon exercise of stock options and release of restricted stock units $ 410   410    
Stock-based compensation 19,486   19,486    
Issuance of common stock in connection with At-the-Market offering, net of issuance costs (In shares)   235,216      
Issuance of common stock in connection with At-the-Market offering, net of issuance costs 18,423   18,423    
Net loss (78,990)       (78,990)
Other comprehensive income 585     585  
Balance as of end of period (in shares) at Sep. 30, 2023   5,842,373      
Balance as of end of period at Sep. 30, 2023 98,709 $ 2 399,847 (252) (300,888)
Balance as of beginning of period (in shares) at Jun. 30, 2023   5,740,154      
Balance as of beginning of period at Jun. 30, 2023 108,417 $ 2 390,240 (401) (281,424)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)   45,311      
Issuance of common stock upon exercise of stock options and release of restricted stock units 60   60    
Stock-based compensation 6,716   6,716    
Issuance of common stock in connection with At-the-Market offering, net of issuance costs (In shares)   56,908      
Issuance of common stock in connection with At-the-Market offering, net of issuance costs 2,831   2,831    
Net loss (19,464)       (19,464)
Other comprehensive income 149     149  
Balance as of end of period (in shares) at Sep. 30, 2023   5,842,373      
Balance as of end of period at Sep. 30, 2023 98,709 $ 2 399,847 (252) (300,888)
Balance as of beginning of period (in shares) at Dec. 31, 2023   7,502,478      
Balance as of beginning of period at Dec. 31, 2023 $ 68,340 $ 2 425,471 (96) (357,037)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares) 51,000 422,725      
Issuance of common stock upon exercise of stock options and release of restricted stock units $ 315   315    
Stock-based compensation 13,041   13,041    
Issuance of common stock in connection with capital raise, net 4,239   4,239    
Issuance of common stock in connection with capital raise, net (in shares)   1,722,449      
Net loss (51,344)       (51,344)
Other comprehensive income 96     96  
Balance as of end of period (in shares) at Sep. 30, 2024   9,647,652      
Balance as of end of period at Sep. 30, 2024 34,687 $ 2 443,066 0 (408,381)
Balance as of beginning of period (in shares) at Jun. 30, 2024   8,611,219      
Balance as of beginning of period at Jun. 30, 2024 52,119 $ 2 437,642 (2) (385,523)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)   293,576      
Stock-based compensation 3,707   3,707    
Issuance of common stock in connection with capital raise, net 1,717   1,717    
Issuance of common stock in connection with capital raise, net (in shares)   742,857      
Net loss (22,858)       (22,858)
Other comprehensive income 2     2  
Balance as of end of period (in shares) at Sep. 30, 2024   9,647,652      
Balance as of end of period at Sep. 30, 2024 $ 34,687 $ 2 $ 443,066 $ 0 $ (408,381)